Pharmaceutical company Cipla has announced the date for its earnings release for the fourth quarter and full year ended March 31, 2025. The company’s Board of Directors is scheduled to meet on Tuesday, May 13, 2025, to consider and approve the standalone and consolidated audited financial results. Based on its past trend, Cipla is expected to announce the results post-market hours on May 13.
The company also indicated that it may recommend a final dividend for FY25 during the upcoming board meeting. Cipla has a history of rewarding shareholders with healthy dividend payouts, with a dividend of ₹13 declared in 2024, up from ₹8.50 in 2023 and ₹5 in 2022.
Additionally, Cipla announced that its trading window for dealing in securities will remain closed from April 1 to May 15, 2025, in compliance with insider trading regulations and in view of the upcoming financial results.
Looking back, Cipla’s Q3 results for FY25 showed a 49% jump in consolidated net profit to Rs 1,571 crore, compared to Rs 1,056 crore in the same quarter a year ago. Revenue from operations grew 7% YoY to Rs 7,073 crore. Sequentially, the net profit rose 21% from Rs 1,303 crore in Q2 FY25, while revenue showed a marginal increase from Rs 7,051 crore.